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Loop-mediated isothermal amplification (LAMP) is a rapid molecular tech-
nique that has been introduced into malaria diagnosis. The test is easy to perform and
offers high sensitivity. We report a 53-year-old male patient who was hospitalized with
fever attacks, chills, and headache caused 9 months after returning from Africa. During
his stay in Africa, he used malaria chemoprophylaxis. Microscopy of thin and thick
blood films and rapid diagnostic antigen testing remained negative for three times. The
EDTA blood samples were tested using the Meridian illumigene® malaria LAMP
assay that gave a positive result for Plasmodium spp. Diagnosis of malaria was
subsequently specified as P. ovale infection by real-time PCR. Ovale malaria often
manifests with delay and low parasitemia. The patient was treated with atovaquone-
proguanil, followed by primaquine for prophylaxis of relapse. This case illustrates the
usefulness of the illumigene® malaria LAMP assay for initial screening of malaria
parasites.
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Introduction
Malaria is diagnosed in travelers returning from endemic regions. The
appropriate management of patients depends on early microbiological diagnosis
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after the onset of symptoms and initiation of the specific therapy to prevent the
progression to severe disease or persistent infection [1]. Standard diagnosis is
based on microscopy of thin and thick blood smears. Sensitivity and specificity of
microscopy is influenced by the practical experience of the laboratory staff [2, 3].
In addition, rapid diagnostic antigen tests (RDTs) are recommended by current
guidelines [1, 4]. RDTs are lateral flow immunochromatographic assays that offer
an easy handling and results within a few minutes, but they are less sensitive than
microscopy and it is qualified only to identification of Plasmodium falciparum
infections, whereas the sensitivities for other species are too low [3]. Although less
common, the prevalence of Plasmodium vivax, Plasmodium ovale, Plasmodium
malariae, and Plasmodium knowlesi is probably underestimated due to often
low parasitemia [5]. In non-endemic settings, molecular tests are new promising
tools that may offer a rapid and accurate screening for exclusion or identification
of malaria parasites in travelers [6]. Polymerase chain reaction (PCR) has been
shown to be highly sensitive and specific but most assays are laborious and
take several hours before results are available, making them less suitable for an
initial screening of patients [7]. An alternative amplification technique that is
simple to perform is provided by loop-mediated isothermal amplification (LAMP).
LAMP offers high-speed amplification under isothermal conditions without the
need of DNA purification because of using a Bst DNA polymerase with strand-
displacement activity [8–10]. The commercially available illumigene® malaria
LAMP assay (Meridian Bioscience/Bioline, Luckenwalde, Germany) is a rapid
molecular test for the detection of Plasmodium spp. in venous EDTA whole blood
specimens, reaching a sensitivity that is comparable with PCR [11]. In this report,
we describe a malaria case caused by P. ovale that would not have been diagnosed
without using a molecular screening assay.
Case Presentation
A 53-year-old male patient was referred to our hospital with chills, fever
attacks up to 39.5 °C for 5 days, and headache. Apart from a type-1 diabetes
mellitus, the medical history of the patient was unremarkable. Nine months before
admission, he was on a backpacking tour in Ghana, Togo, and Benin and he had
traveled to Greece recently. During his visit to Africa, he used malaria prophylaxis
as recommended (atovaquone-proguanil; Aliud Pharma, Laichingen, Germany).
He was presented at the hospital admission with elevated levels of C-reactive
protein (CRP; 119.2 mg/L), procalcitonin (0.90 ng/ml), lactate dehydrogenase
(489.6 U/L), aspartate aminotransferase (36 U/L), bilirubin (53 μmol/L), and a
decreased platelet count of 61 Gpt/L. White blood cells were within the normal
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range (4.7 Gpt/L). The initial blood pressure was 120/70 mmHg, the heart rate was
88/min, and the respiratory rate was within the normal range. Abdominal
ultrasound revealed splenomegaly (18 cm) and a chest X-ray showed pulmonary
infiltrations. Blood cultures were taken three times but remained sterile.
An antibiotic treatment with ampicillin/sulbactam was initiated but did not lead
to an improvement of the elevated CRP level (121.4 mg/L on Day 4) or of clinical
symptoms. Procalcitonin increased to 4.74 ng/ml and antibiotic therapy was
escalated to piperacillin/tazobactam. Laboratory evaluation showed increasing
bilirubin (65 μmol/L), aspartate aminotransferase (336 U/L), and alanine amino-
transferase (294 U/L). As haptoglobin was below lower limit of detection and
hemoglobin was decreased to 5.5 mmol/L, a diagnosis of hemolysis could be made
in combination with elevated levels of bilirubin and lactate dehydrogenase. A
computed tomography evaluation of thorax and abdomen was performed, but
despite a hepatosplenomegaly, no infectious focus could be identified. Dengue
fever RDT was negative. The patient had received vaccination against yellow
fever before traveling. We could detect IgG antibodies with an 1:160 titer without
IgM antibodies. PCR for Leishmania spp. from an EDTA blood sample remained
negative. Because of the travel history, malaria testing was performed. Repeated
microscopy of thick and thin blood films on three consecutive days and RDT
(BinaxNow® Malaria; Alere Technologies, Cologne, Germany) were negative.
The antigen targets of the RDT included the P. falciparum-specific histidine-rich
protein 2 and the Plasmodium genus-specific aldolase [12]. All microscopic slides
were examined by a specialist in malaria diagnosis.
In addition, molecular diagnostic was performed using the illumigene®
malaria LAMP assay that targets a sequence of Plasmodium spp. mitochondrial
DNA non-coding region conserved across P. falciparum, P. vivax, P. ovale,
P. malaria, and P. knowlesi. An amount of 50 μl of EDTA blood was added to a
ready-to-use tube containing lysis buffer I and incubated at room temperature for
2 min. An amount of 50 μl of the lysate was transferred into the sample preparation
tube and filtered into a clean Eppendorf tube. Each 50 μl of the filtrate was pipetted
into both the test and internal control chamber of the test device containing
lyophilized master mixes. The test was run in an illumipro-10 machine (Meridian
Bioscience) for 40 min. The EDTA whole blood sample of the patient was tested
positive for Plasmodium spp. For species identification, an aliquot was sent to the
German National Reference Center for Tropical Pathogens at the Bernhard Nocht
Institute for Tropical Medicine (Hamburg, Germany). Plasmodium infection was
confirmed by real-time PCR (RealStar Malaria PCR Kit 1.0; altona Diagnostics,
Hamburg, Germany) and P. ovale was identified as the causative species using
species-specific in-house multiplex PCR [6]. Therapy with atovaquone-proguanil
was initiated, followed by a 14-day course of primaquine for prophylaxis of
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relapse. With this treatment, fever disappeared, the general condition improved,
and CRP levels and platelet counts normalized. At the time of discharge from
hospital, CRP was 2.6 mg/L and platelet count was 286 Gpt/L. Liver enzymes
were decreasing and gave a negative result at a control 4 weeks after discharge.
Anemia disappeared and haptoglobin, bilirubin, and lactate dehydrogenase were
normalized as well.
Discussion
Current US and European guidelines recommend microscopy of thick and
thin blood films combined with RDT as standard procedures for the diagnosis of
malaria [13, 14]. To rule out infection, febrile patients returning from malaria-
endemic regions have to be tested three times because microscopy cannot reliably
identify parasite numbers <50/μl [1, 2]. RDTs detect ≥100–200 parasites/μl and
have a low sensitivity for identification of non-P. falciparum infections, especially
for P. malariae and P. ovale as observed in this case [4, 12, 15, 16]. Limitations to
identify infections with low parasitemia can be overcome by PCR that can detect
<5 parasites/μl [8, 9, 17, 18]. LAMP also has an adequate analytical sensitivity to
detect low parasite-level parasitemia, compared to PCR [7, 10, 11].
The illumigene® malaria test is a simple and rapid molecular diagnostic test
allowing its integration into a 24/7 routine workflow. Because of a simplified
sample preparation step and ready-to-use reagents, no technical expertise in
molecular biology is needed and the results can be obtained within 1 h. In a
recent study, both sensitivity as well as specificity of LAMPwas found to be 100%
versus microscopy when discrepant results were resolved using PCR [11].
Therefore, the illumigene® malaria test represents a useful and cost-effective tool
for emergency diagnostics [6, 7]. Because of its high negative predictive value, it
has been suggested that the current test algorithm of three microscopic tests to rule
out an infection can be replaced by a single LAMP test, thereby reducing the
inconvenience for the patient and saving costs [11].
In this case report, we presented a patient who developed unspecific
symptoms 9 months after a travel to West Africa. P. ovale infection would not
have been identified without a sensitive molecular test. P. ovale, which is now
separated into the two sympatric species Plasmodium ovale curtisi and Plasmo-
dium ovale wallikeri, is generally linked to rather mild disease but severe
complications can develop [19]. The delay in the manifestation of symptomatic
disease is characteristic even when atovaquone/proguanil chemoprophylaxis has
been used. Liver hypnozoites of P. ovale probably arrest early enough during the
developmental cycle and may not be eliminated by anti-malaria drugs [20].
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Because a late onset of disease after P. ovale or P. vivax infection is observed in a
major part of the patients, it is recommended to consider malaria within 2 years
after people return from endemic areas. This case illustrates that the integration of
the illumigene® malaria LAMP assay into the diagnostic algorithm for malaria
infections is beneficial in patients with a low density of parasites in peripheral
blood.
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